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Abstract
Introduction: We describe a case of non-small cell lung cancer that was found to stain positive for beta-human
chorionic gonadotropin on immunohistochemistry. Only a few case reports have described lung cancers that
secrete beta-human chorionic gonadotropin.
Case presentation: A 68-year-old Caucasian man presented with symptoms of weakness, fatigue and weight loss
for the past two months. On examination, he was found to have generalized lymphadenopathy, and radiologic
workup revealed numerous metastases in the lungs, liver and kidneys. Biopsy of the supraclavicular lymph node
revealed metastatic large cell lung cancer with beta-human chorionic gonadotropin hormone positivity. The serum
beta-human chorionic gonadotropin level was 11,286 mIU/ml (upper limit of normal, 0.5 mIU/ml in non-pregnant
females). He was diagnosed with stage 4 lung non-small cell lung cancer. The patient refused chemotherapy. He
was discharged home with hospice care.
Conclusion: The markedly elevated serum values of beta-human chorionic gonadotropin initially prompted the
medical team to investigate germinal tumors. In the presence of a negative testicular ultrasound, workup was
performed to find an extratesticular source of the tumor. Finally, the diagnosis was made with a tissue biopsy. This
case illustrates that atypical markers can be seen in many cancers, emphasizing the role of immunohistochemistry
and tissue biopsy in establishing the diagnosis.
Introduction
b-human chorionic gonadotropin (b-hCG) is commonly
produced by germ cell tumors and seldom produced by
other tumors. In the literature, a few case reports dis-
cuss the ectopic production of b-hCG in small cell and
non-small cell lung cancers. We present an unusual case
of lung cancer with ectopic production of b-hCG.
Case presentation
A 68-year-old Caucasian male patient with medical his-
tory significant for depression, emphysema, and gastroe-
sophageal reflux disease presented to his primary care
physician for a routine office visit. Medications at home
included paroxetine, tiotropium, and omeprazole. Blood
work revealed a hemoglobin level of 7.4 mg/dl with a
hematocrit of 20 mg/dl, and then he was sent to the
Emergency Department for transfusion. He reported
that he had experienced decreased appetite and signifi-
cant weight loss for the past two months. He had never
seen a primary doctor until recently, when he was diag-
nosed with depression, emphysema, and gastroesopha-
geal reflux disease. Family history was significant for a
sister with colon cancer and his mother with multiple
myeloma. He was a long-term smoker with an 80-pack-
year history of smoking. On physical examination, vital
signs were BP, 112/68 mm Hg; RR, 16/minute; PR, 88/
minute; and temperature, 97.9°F. Chest auscultation
revealed diffusely scattered coarse rhonchi. The abdo-
men was soft with no organomegaly. The testes were
soft and were not enlarged. No lymphadenopathy was
noted.
In the context of the anemia and the recent weight
loss, a workup for malignancy was initiated. The patient
underwent colonoscopy and esophagogastroduodeno-
scopy (EGD). No polyps or ulcerated lesions were noted
on the colonoscopy. The EGD revealed esophageal can-
didiasis and chronic gastritis. Computed tomography
scans of the chest, abdomen, and pelvis revealed
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clavicular, paraesophageal, paratracheal, and subcarinal
lymph nodes were enlarged and a 2.3 cm right hilar
mass was seen. Multiple nodules were found in the
lungs bilaterally, the largest one measuring 2.7 cm in
diameter. A 2.5 cm mass was noted in the periphery of
the left upper lobe (Figure 1). Several hypodensities
were noted in the kidneys, liver, and spleen (Figure 2).
An ill-defined necrotic retroperitoneal mass measuring
14.4 cm, encasing the abdominal vasculature, was seen
in the periaortic and aortocaval areas (Figure 3). At that
point, the working diagnosis was metastasis with an
unknown primary tumor. Differential diagnoses included
lung cancer and germ cell tumors. Further blood work
revealed a b-hCG level of 11,286 mIU/ml. a-Fetoprotein
and prostate-specific antigen were negative. Ultrasound
of the testes revealed neither testicular enlargement nor
lesions. At that point, the possibility of primary testicu-
lar germ cell tumor was excluded. On day 4, the patient
underwent a left supraclavicular lymph node excision.
The histopathology revealed metastatic poorly differen-
tiated squamous cell carcinoma with focal positivity for
b-hCG (Figures 4 and 5). Immunohistochemistry
revealed CK, 7; AE1/AE3, b-hCG, CAM 5.2, and P63
positivity (Figure 6). CK 20, CEA, CA 19-9 AFP, and
TTF were negative (Figure 7). These markers were con-
sistent with a poorly differentiated or undifferentiated
non-small cell carcinoma (squamous type) with b-hCG
positivity. He was diagnosedw i t hs t a g e4l u n gc a n c e r
with ectopic secretion of b-HCG. The patient and the
family opted for palliative treatment.
Conclusion
Lung cancer is the most common cause of worldwide
cancer mortality in men and women, causing approxi-
mately 1.2 million deaths per year [1].
Ectopic beta human chorionic gonadotropin (b-hCG)
expression by non-gestational tumors was noted in
the early 1900s, and b-hCG secretion has been noted
in gastric, ovarian, liver, and lung cancers [2]. Despite
this, lung cancer with b-hCG production is rare, and
only a few case reports have been published in the
literature [3-5].
We do not know why non-gestational cells produce
b-hCG. Several studies have tried to look into b-hCG
production. In a study published from Japan, mRNA
transcripts of the beta gene were detected in lung cancer
tissues, and the result of the study was that b-hCG
Figure 1 Right hilar mass noted with multiple pulmonary
nodules scattered throughout the lung parenchyma.
Figure 2 Multiple hypodensities noted in the liver, and an
isolated lesion noted in the head of the spleen.
Figure 3 A massive conglomerate of periaortic, aortocaval
lymph nodes and retroperitoneal necrotic mass measuring up
to 14.4 cm, which encases the abdominal vasculature.
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cells [6].
How b-hCG acts also is not clear. Some studies have
i n d i c a t e dt h a ti ta c t sa sa na u t o c r i n eo rp a r a c r i n e
growth factor or both by inhibiting apoptosis [7].
In vitro studies suggest that b-hCG may inhibit trans-
forming growth factor beta (TGF-b) receptor complex
by binding to a component of the receptor complex,
thus blocking its binding sites. This prevents further
interactions with other receptor components, eventually
leading to apoptosis [7]. This may explain why b-hCG-
producing tumors appear to be more aggressive and
have a worse prognosis.
Similarly, other studies have shown that small cell lung
cancer with b-hCG production results in a more-resistant
tumor and worse prognosis, in chemoresistance, and that
elevated b-hCG values are more commonly seen in
patients with metastatic disease [8,9].
Figure 4 Biopsy of supraclavicular lymph node showing undifferentiated giant cells.
Figure 5 Immunohistochemistry showing focal positivity for
b-hCG.
Figure 6 Immunohistochemistry showing cells that stain
positive for P63, highly suggestive of squamous cell carcinoma.
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nized phenomenon, and studies have shown that its pro-
duction by non-gestational tumors indicates a poorer
prognosis, it is not clear whether it should be widely
used as a prognostic marker and routinely measured in
the patient’s serum.
The mechanism of b-hCG production by the tumor
cells is not well understood, and the action is at best
speculative. Only a few studies have been done in this
field, and more is required before it can be stated defi-
nitely that lung cancer with ectopic b-hCG production
is indeed associated with a worse prognosis, worse stage,
and chemoresistance.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
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Figure 7 Immunohistochemistry showing positivity for CK 7 on
the cell membrane, suggestive of a carcinoma, most likely lung.
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